1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Thomas Brown
Thomas Brown
Articles (5983) 

This Stock's Undervalued by 28%. We Rate It "Hold."

November 05, 2010 | About:

Some of my gripes about the sell-side never get old. This is from a note on published last week, by an analyst who shall remain nameless, on Synovus (NYSE:SNV). The stock’s price on date of publication was $2.34.:

SNV shares carry at least $3.00 of franchise value today after taking a credit mark of about $850 million of ongoing credit losses through 2011, adding back a deposit premium just under 4%, and using Tier 1 Common (excluding all TARP & Trust Preferred capital). Yes, this figure should build to about $3.30 at the end of 2011 and would be higher in 2012 if the DTA (deferred tax asset) valuation allowance is partially or fully recaptured. But, we think investors are unlikely to pay in advance for this valuation discrepancy. In fact, a present value of franchise value we estimate for year-end 2011 is only $2.88, only modestly above the current trading price. While 3Q10 results showed a slightly reduced loss, we continue to forecast negative EPS results through mid-2011 as the company’s cumulative loan losses trend towards 18% of peak loan balances (i.e., which compares to 14.9% so far the past 15 quarters—including OREO write-downs). While it is possible that loan resolutions are accelerated in the next two quarters (which we would prefer), we still believe true profitability is not until 2H-2011. Thus, we think the stock may continue to trade at a discount to both our future forecast of Franchise Value (see table on Page 4) but also closer to the present value of our future P/E range of 10x to 11x Normalized EPS of $0.32 in 2012. . . . Our rating remains “Market-Perform.” [Emph. added]

Might we review those numbers?

  • Our anonymous analyst says that Synovus’s franchise value, assuming ample incremental credit losses through next year, but not including a 88-cent-per-share deferred tax asset the company will almost surely recover once it returns to profitability, is $3.00 per share—or 28% above its stock price at time of publication.

  • He says the net present value of Synovus’s projected yearend 2011 franchise value of $3.30—again excluding the DTA—calculated using a highly generous discount rate of 14%, is $2.88 per share—or 23% above its stock price.

  • He says the stock should trade at roughly 10.5 times its normalized earnings of 32 cents per share. That works out to $3.36 per share—or 44% higher than its current stock price.

So depending on the calculation you prefer, by the analyst’s own numbers Synovus is undervalued by anywhere from 23% to 44%. And yet our man rates the stock “Market-Perform.” Gggggoink!

I should add, in case you’re suspicious I’m leaving something out, that the company is lavishly capitalized, thanks to a $1 billion equity offering it did in April (that we were none too thrilled with, by the way). At the end of the third quarter, Tier 1 capital stood at 9.5%. Meanwhile, no one disputes that the company’s credit issues are clearly and decisively improving. I say Synovus returns to profitability the first quarter of next year. Our Mystery Analyst says it will be the fourth quarter. Given that the company lately trades at 75% of tangible book, which quarter exactly Synovus starts to make money again seems slightly beside the point. Oh, and the deferred tax asset that our man seems determined to ignore is not immaterial. Assuming that crazily high 14% discount rate that seems to have been plucked out of the air, he notes it would adds 72 cents per share to what the stock should be worth here and now.

Good heavens. One of the few positives for the sell-side to come out of the credit crackup is the opportunity it is lately providing analysts to make valuation calls (and stock recommendations) that are plainly, blindingly obvious. Here is a company, for example, that even according to assumptions that are surely designed to be overly conservative, has upside of 25% to 45%. (According to more realistic assumptions, I can’t help but add, the upside is closer to 100%.) And he is neutral. What more in the world can these people want?

What do you think? Let me know!

(Note: We have a position in Synovus.)

Thomas Brown


Rating: 5.0/5 (3 votes)


Paulwitt - 6 years ago    Report SPAM
Don't know about SNV but Banner made a good move today....

Disclosure: I bought BANR in the past based on insider buying and book value. I do not hold a position


Tkervin - 6 years ago    Report SPAM
Analyst's stock estimations are, in the main, worthless. Earnings estimates are, in the main, worthless. I don't know why any experienced investor would waste time on them. Now there are exceptions. Particular analysts that have a proven track record, over long time periods. I find better value in following the Gurus. They are putting their money where their mouth is.
Batbeer2 premium member - 6 years ago
And yet our man rates the stock “Market-Perform.” Gggggoink!

It is logical to rate a cheap stock Market-Perform if you think the market in general is just as cheap.

This may or may not be a good analyst and SNV may or may not be the best idea out there but, at face value, there is nothing wrong with the logic.

It seems to me you are vexed because this analyst is not rating a stock you like "buy". If you really like SNV, send him a box of chocolates and increase your position.

my 2 cts.
Davethebooker - 6 years ago    Report SPAM
Initial rate of return is no calculable.

The roe is negative.

The Roc is not good.

The eps over the last 10 years... is rough to say the least. It looks like rodeo ride.

The amount of shares in the last 10 years has doubled. 250 million to 500 million. Bad.Now I know how they raise money . Sell stock .

Lossing money last few years.

Cash on hand is slim.

Book value shrinking.

The Roe and Margin used to be good. Can it recover ? Not sure.

D/e is a little high. Naturally.

Been doin business for over 21 years.

Its eps and its growth well it isnt good.

So the question is can I make money here ?

And will the stock recover ? How long will it take ? Should I go Further ?

Not sure , but it looks terrible.

Dont know , and I don care.

A few years to recover but it may go under.


What is the risk here. Large.

Oh and there is one other thing. It really doesnt have a competitive advantage

Now I understand that the numbers are messed up do to the houseing market.

But even before that the numbers where not what I look for.

This is out of my circle of investment and understanding.

I would not reccomend to my clients or myself. But that is just me.

I also see no value here. At this time.

Please leave your comment:

Performances of the stocks mentioned by Thomas Brown

User Generated Screeners

bpatton23L/Cap value
AJPringAP screen102017 NO LOW
Nightdoc2Large Value
DBrizan2017 oct20CDN
DBrizan2017 oct20CDN dividend
althekearoct 17 user defined screen
althekearPE >50th percentile of INDUSTR
althekearLow EV/EBITDA
althekearLynch inspiret Oct 17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat